Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics

ADVOR is the largest randomized diuretic trial in AHF, investigating acetazolamide to improve decongestion on top of standardized loop diuretics. The elderly enrolled population with poor quality of life provides a good representation of the real-world AHF population. The pragmatic design will provide novel insights in the diuretic treatment of patients with AHF.